Virtual Clinical Trials, an Essential Step in Increasing the Effectiveness of the Drug Development Process

Publisher： Karger

E-ISSN： 1662-8063|18|6|366-371

ISSN： 1662-4246

Source： Public Health Genomics, Vol.18, Iss.6, 2015-0, pp. : 366-371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decision-Making Process Related to Participation in Phase I Clinical Trials: A Nonsystematic Review of the Existing Evidence

By  

Public Health Genomics, Vol. 18, Iss. 6, 2015-0 ,pp. : 359-365

Karger

Access to resources Recommend Favorite

Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies

By Chan Yiumo Michael   Keramaris-Vrantsis Elizabeth   Lidov Hart G.   Norton James H.   Zinchenko Natalia   Gruber Helen E.   Thresher Randy   Blake Derek J.   Ashar Jignya   Rosenfeld Jeffrey   Lu Qi L.  

Human Molecular Genetics, Vol. 19, Iss. 20, 2010-10 ,pp. : 3995-4006

Oxford University Press

Access to resources Recommend Favorite

Precautionary Harm Disclosure in Clinical Trials

By Wu Kevin Chien-Chang  

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 43-45

Routledge Ltd

Access to resources Recommend Favorite

Clinical Trial Transparency and Orphan Drug Development: Recent Trends in Data Sharing by the Pharmaceutical Industry

By  

Public Health Genomics, Vol. 16, Iss. 6, 2014-02 ,pp. : 322-335

Karger

Access to resources Recommend Favorite

Can Contracts Enhance Participant Autonomy in Clinical Trials?

By Buccafurni Diana  

American Journal of Bioethics, Vol. 11, Iss. 4, 2011-04 ,pp. : 24-25

Routledge Ltd

Access to resources Recommend Favorite